Very interesting cardiovascular disease statistics were released in JACC. Hypertension treatment and control rates have remained stagnant over the past 15 years, and related deaths have doubled. The prevalence of diabetes is higher in younger adults, with poor glycemic control.

Show Post

📢 Don’t miss the next #CardioCore Lecture Series! 🫀 Residual Risk of Cardiovascular Disease 📅 Monday, Sept 22, 2025 | ⏰ 6–7 PM CDT | 💻 Virtual 🎙️ Featuring Vijay Nambi, MD (BCM Medicine – Athero & Lipo) Join us! ow.ly/6hzx50WWtJm #HeartHealth #CVDPrevention #CardioSky #MedSky @ajpcardio.bsky.social

Show Post

In the SUMMIT trial greater weight loss on treatment with tirzepatide was associated with greater improvements in 6MWD and KCCQ in HFpEF #obesity www.jacc.org/doi/10.1016/...

Show Post

🎧 New #JACC This Week podcast 🔬 Valve underexpansion & outcomes in ACURATE IDE 💉 Body composition & tirzepatide in HFpEF 🏥 Private equity & heart failure care 🫀 Multivalve disease challenges 🧾 Brief reports+more ▶️ Listen: www.jacc.org/digital-cont... #cardiotwitter @jaccjournals.bsky.social

Show Post

Amazing editorial by Sniderman et al - sadly firewalled - "Incorporating apoB & Lp(a) into routine clinical care will improve assessment of CV risk & will radically simplify RX —and therefore radically improve—the capacity of all caregivers globally to prevent CVD. doi.org/10.1093/eurh...

Show Post